- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Swedish Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
11
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
11 companies
Xbrane Biopharma
Market Cap: SEK 437.0m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.28
7D
5.9%
1Y
11.5%
Bonesupport Holding
Market Cap: SEK 21.2b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 323.00
7D
-0.4%
1Y
8.4%
Guard Therapeutics International
Market Cap: SEK 394.3m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 20.10
7D
-0.5%
1Y
-30.7%
Devyser Diagnostics
Market Cap: SEK 2.5b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 150.00
7D
12.3%
1Y
34.5%
Klaria Pharma Holding AB (publ.)
Market Cap: SEK 86.9m
A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.
KLAR
SEK 0.56
7D
-3.5%
1Y
65.6%
Diamyd Medical
Market Cap: SEK 1.6b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 11.66
7D
20.2%
1Y
-33.1%
Egetis Therapeutics
Market Cap: SEK 2.2b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 6.09
7D
11.9%
1Y
-3.8%
SynAct Pharma
Market Cap: SEK 1.0b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 21.50
7D
-1.4%
1Y
153.2%
Mendus
Market Cap: SEK 520.8m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 8.72
7D
12.4%
1Y
7.0%
Genovis AB (publ.)
Market Cap: SEK 1.9b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 28.90
7D
3.8%
1Y
-1.5%
Swedencare
Market Cap: SEK 6.5b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 39.75
7D
-14.6%
1Y
-11.5%